bay y3118 has been researched along with carbostyril in 31 studies
Studies (bay y3118) | Trials (bay y3118) | Recent Studies (post-2010) (bay y3118) | Studies (carbostyril) | Trials (carbostyril) | Recent Studies (post-2010) (carbostyril) |
---|---|---|---|---|---|
37 | 0 | 0 | 12,855 | 1,323 | 5,611 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (87.10) | 18.2507 |
2000's | 4 (12.90) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bremm, KD; Endermann, R; Metzger, KG; Petersen, U | 1 |
Carlyn, CJ; Doyle, LJ; Knapp, CC; Ludwig, MD; Washington, JA | 1 |
Fresnadillo-Martínez, MJ; García-García, MI; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Trujillano-Martín, I | 1 |
Bauernfeind, A | 1 |
Citron, DM; Goldstein, EJ; Nesbit, CA | 1 |
Pirali, F; Pizzi, R; Ravizzola, G; Turano, A | 1 |
Heilmann, HD; Sirgel, FA; Venter, A | 1 |
García, I; Pascual, A; Perea, EJ | 1 |
Bauer, J; Budeanu, C; Hof, H; Kretschmar, M; Linss, W; Nichterlein, T | 1 |
Aldridge, KE | 1 |
Fresnadillo, MJ; García-García, MI; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Trujillano-Martín, I | 1 |
Borobio, MV; Conejo, M; Perea, EJ; Ramirez, E; Suarez, AI | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Jin, YF; Marshall, AJ; Piddock, LJ | 1 |
Lindmark, A; Nord, CE; Persson, I | 1 |
Bongaerts, GP; Hoogkamp-Korstanje, JA | 1 |
Fass, RJ | 1 |
Finegold, SM; Molitoris, E; Wexler, HM | 1 |
Schaefer, HG | 1 |
Andrews, JM; Brenwald, N; Wise, R | 1 |
Molinari, G; Schito, GC | 1 |
Bébéar, C; Renaudin, H | 1 |
Verbist, L; Verhaegen, J | 1 |
Schlüter, G; Schmidt, U | 1 |
Barbara-Burnham, L; Bermudez, LE; Inderlied, CB; Kolonoski, P; Wu, M; Young, LS | 1 |
Hof, H; Nichterlein, T; Walz, A | 1 |
Chen, D; Prahalad, AK; Rosen, JE; Schluter, G; Spratt, TE; Williams, GM | 1 |
Agapakis-Causse, C; Marrot, L | 1 |
Castell, JV; Morlière, P; Ouédraogo, G; Santus, R | 1 |
Ahr, HJ; Blotz, A; Blümel, J; Dubertret, L; Michel, L; Moysan, A; Vohr, HW | 1 |
Agapakis-Causse, C; Belaidi, JP; Chaubo, C; Marrot, L; Meunier, JR; Perez, P | 1 |
31 other study(ies) available for bay y3118 and carbostyril
Article | Year |
---|---|
In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation; Quinolones; Time Factors | 1992 |
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Spiro Compounds | 1995 |
In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoxitin; Chloramphenicol; Clindamycin; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Quinolones | 1995 |
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Wound Infection | 1995 |
In vitro antibacterial activity of the new quinolone Bay y3118 against clinical isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones | 1994 |
Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Quinolones; Sputum; Tuberculosis, Pulmonary | 1995 |
Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Neutrophils; Quinolones; Staphylococcus aureus | 1994 |
Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells.
Topics: Ampicillin; Animals; Anti-Infective Agents; Cell Line; Chronic Disease; Female; Fluoroquinolones; Interferon-gamma; Interleukin-6; Listeria monocytogenes; Listeriosis; Liver; Mice; Mice, Nude; Microbial Sensitivity Tests; Microscopy, Electron; Quinolones; Spleen | 1994 |
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1994 |
Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis.
Topics: Anti-Infective Agents; Brucella melitensis; Brucellosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1994 |
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1994 |
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1993 |
Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phenotype; Quinolones | 1994 |
In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Anaerobic; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1993 |
In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Topics: Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections | 1993 |
In vitro activity of Bay y 3118, a new quinolone.
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Regression Analysis | 1993 |
In vitro activity of Bay Y3118 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1993 |
Determination of BAY y 3118, a novel 4-quinolone, in biological fluids using high-performance liquid chromatography and photothermal post-column derivatization.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Indicators and Reagents; Male; Photochemistry; Quinolones; Spectrometry, Fluorescence | 1993 |
The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Chlamydia; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Lactams; Microbial Sensitivity Tests; Quinolones; Species Specificity; Staphylococcus | 1993 |
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma; Quinolones; Staphylococcus aureus; Tetracycline Resistance | 1995 |
Comparative in vitro activity of BAY Y 3118 against selected species.
Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
Studies on the mechanism of phototoxicity of BAY y 3118 and other quinolones.
Topics: Animals; Anti-Infective Agents; Biomarkers; Dermatitis, Phototoxic; Fluoroquinolones; Free Radical Scavengers; Guinea Pigs; Kinetics; Photochemistry; Quinolones; Rats; Ultraviolet Rays; Vitamin E | 1996 |
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
Topics: Animals; Anti-Infective Agents; Cell Line; Drug Combinations; Ethambutol; Female; Fluoroquinolones; Humans; Levofloxacin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rats | 1996 |
Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Fluoroquinolones; Gentamicins; Legionella pneumophila; Legionnaires' Disease; Macrophages; Mice; Penicillins; Quinolones; Tumor Cells, Cultured | 1997 |
A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Aza Compounds; Cell Line; Deoxyguanosine; Epithelium; Fluoroquinolones; Liver; Moxifloxacin; Quinolines; Quinolones; Rats; Ultraviolet Rays | 1997 |
Differences in the photogenotoxic potential of two fluoroquinolones as shown in diploid yeast strain (Saccharomyces cerevisae) and supercoiled plasmid DNA.
Topics: Adenosine Triphosphatases; Anti-Infective Agents; Cell Division; Diploidy; DNA Helicases; DNA, Superhelical; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluoroquinolones; Mutagenicity Tests; Mutation; Photosensitizing Agents; Plasmids; Quinolones; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Time Factors; Ultraviolet Rays | 2000 |
Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones.
Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Cytoplasm; Fibroblasts; Fluoroquinolones; Humans; Mitochondria; Norfloxacin; Ofloxacin; Photosensitizing Agents; Quinolones; Skin | 2000 |
Analyses of cutaneous fluoroquinolones photoreactivity using the integrated model for the differentiation of skin reactions.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Biomarkers; Cell Membrane; Enoxacin; Female; Fluoroquinolones; Irritants; Mice; Models, Biological; Ofloxacin; Phenotype; Photosensitizing Agents; Quinolones; Skin | 2000 |
Fluoroquinolones as chemical tools to define a strategy for photogenotoxicity in vitro assessment.
Topics: Anti-Infective Agents; Cell Line; Comet Assay; DNA Damage; DNA, Superhelical; Fluoroquinolones; Humans; In Vitro Techniques; Melanocytes; Monophenol Monooxygenase; Mutagenicity Tests; Photochemistry; Pigmentation; Quinolones; Saccharomyces cerevisiae; Skin; Tumor Suppressor Protein p53; Ultraviolet Rays | 2001 |